IP Library Granted Patent US 7,855,062
Granted Patent B2
US 7,855,062 · App. 11/304,492 · Granted Dec 21, 2010

Bone cell delivery device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,855,062
App. No.
11/304,492
Granted
Dec 21, 2010
Kind
B2
Abstract

Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to subjects.

Claims (44)

1. A device for administering one or more biologically active materials to a subject, comprising:

one or more biologically active materials that do not include bone tissue, wherein the one or more biologically active materials include at least one of biologically active molecules or cells; and

a porous bone cage at least partially forming an internal cavity having the one or more biologically active materials disposed therein, the porous bone cage including a scaffold with living bone cells having decreased immunogenicity, the porous bone cage configured to selectively allow passage of the one or more biologically active materials therethrough.

2. The device of claim 1 , wherein the living bone cells are differentiated from stem cells in vitro.

3. The device of claim 2 , wherein the stem cells are selected from the group consisting of fetal, embryonic, cord, mesenchymal and hematopoietic stem cells.

4. The device of claim 1 , wherein the device is biocompatible.

5. The device of claim 1 , further comprising:

a semi-permeable membrane, wherein the porous bone cage at least partially surrounds the semi-permeable membrane.

6. The device of claim 1 , further comprising:

a semi-permeable membrane, wherein the semi-permeable membrane at least partially surrounds the porous bone cage.

7. The device of claim 5 , wherein the semi-permeable membrane at least partially surrounds the one or more biologically active materials.

8. The device of claim 5 , wherein the semi-permeable membrane is autologous, allogeneic or xenogeneic with respect to the subject.

9. The device of claim 5 , wherein the semi-permeable membrane is non-immunogenic with respect to the subject.

10. The device of claim 5 , wherein the semi-permeable membrane is recognized as self by the subject.

11. The device of claim 1 , wherein the one or more biologically active materials are produced by one or more living cells or tissues.

12. The device of claim 11 , wherein the one or more living cells or tissues are at least partially enclosed by a semi-permeable membrane.

13. The device of claim 12 , wherein the semi-permeable membrane is at least partially surrounded by the porous bone cage.

14. The device of claim 11 , wherein the one or more living cells or tissues are autologous.

15. The device of claim 11 , wherein the one or more living cells or tissues are genetically engineered.

16. The device of claim 11 , wherein the one or more living cells or tissues are non-immunogenic with respect to the subject.

17. The device of claim 1 , wherein the living bone cells are autologous.

18. The device of claim 1 , wherein the living bone cells bind the one or more biologically active materials.

19. The device of claim 1 , wherein the living bone cells are treated to at least partially prevent restructuring in the subject.

20. The device of claim 1 , wherein the living bone cells are treated to enhance restructuring in the subject.

21. The device of claim 1 , wherein the living bone cells are at least partially resorbable.

22. The device of claim 1 , wherein the living bone cells are immunogenic with respect to the subject.

23. The device of claim 1 , wherein the living bone cells are non-immunogenic with respect to the subject.

24. The device of claim 1 , wherein the living bone cells are recognized as self by the subject.

25. The device of claim 1 , wherein the living bone cells are genetically engineered.

26. The device of claim 25 , wherein the living bone cells are genetically engineered to at least partially prevent restructuring.

27. The device of claim 25 , wherein the living bone cells are genetically engineered to enhance restructuring.

28. The device of claim 1 , wherein the subject is an animal.

29. The device of claim 28 , wherein the animal is selected from the group consisting of a domesticated animal, a farm animal, a marine animal, a sport animal, a wild animal, a research animal, a zoo animal, a bird, an amphibian, a reptile, a fish and a mammal.

30. The device of claim 29 , wherein the mammal is a human.

31. The device of claim 1 , wherein the porous bone cage includes a semi-permeable membrane.

32. The device of claim 31 , wherein the semi-permeable membrane is autologous with respect to the subject.

33. The device of claim 31 , wherein the semi-permeable membrane is allogeneic with respect to the subject.

34. The device of claim 31 , wherein the semi-permeable membrane is xenogeneic with respect to the subject.

35. The device of claim 6 , wherein the semi-permeable membrane surrounds the porous bone cage.

36. The device of claim 7 , wherein the semi-permeable membrane surrounds the one or more biologically active materials.

37. The device of claim 11 , wherein the one or more living cells or tissues are enclosed by a semi-permeable membrane.

38. The device of claim 11 , wherein the one or more living cells or tissues are immunogenic with respect to the subject.

39. The device of claim 5 , wherein the semi-permeable membrane includes cells with tight junctions, one or more plasma membranes, one or more intracellular membranes, one or more red blood cell ghosts, and one or more aggregated platelets or other cells.

40. The device of claim 6 , wherein the semi-permeable membrane includes cells with tight junctions, one or more plasma membranes, one or more intracellular membranes, one or more red blood cell ghosts, and one or more aggregated platelets or other cells.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2010
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 024695/0813 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2006
From: HARLOW, ED; HYDE, RODERICK A.; JUNG, EDWARD K.Y.; LANGER, ROBERT; LEUTHARDT, ERIC C.; WOOD, LOWELL L., JR.
To: SEARETE LLC
Reel/Frame 017530/0707 →